What is ISoP?
The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. more…
COVID-19 Information
ISoP Webinar
ISoP Boston Seminar 2020
10-11 December 2020
Intelligent Automation in Pharmacovigilance.
READ MORE
PSD 2020
ISoP-UMC
ISoP-UMC Training
China
Pharmacovigilance systems in China: Moving to the next step.
ISoP Chapters Activities
Middle East Chapter meeting
27 January 2021
READ MORE
Latin America Chapter Webinar series
04-10-18-25 February 2021
READ MORE
Egypt Chapter training
20-22 January 2021
ISoP Training
ISoP Symposium & Training
Moscow, Russia, Spring 2021
Please note important information
Moving Pharmacovigilance Forward in the Eurasian Economic Union (EAEU)
READ MORE
ISoP 2021
Annual Meeting
Muscat, Oman, 11-14 October 2021
Please note important information
Integrated Pharmacovigilance for Safer Patients
READ MORE
What’s New
New ISoP membership fees 2021 and Membership Categories
Successful #MedSafetyWeek campaign
Article published by NZ Pharmacy Today magazine about World Pharmacist Day and the ISoP statement in support of pharmacists worldwide
ISoP statement in support of World Pharmacist Day, 25 September 2020
New ISoP infographic ‘Using Medicines Safely during the COVID-19 pandemic’
COVID-19 Information
ISoP President’s message
ISoP editorials in Drug Safety journal
CIOMS Establishes Annual Award for Medical Students
Updated ISoP Privacy Policy
ISoP Latest
President of ISoP
I am honoured and delighted to have been elected as President of ISoP – as announced on 28th October 2019 at our Annual General Meeting in Bogota – and am especially proud to be the first woman to ever hold this role in our professional society.
Mira Harrison‐Woolrych
President – International Society of Pharmacoviliance
Drug Safety
ISoP Official Journal
Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management.